Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association ( conduct of Sunesis' clinical trials and...)

HOME >> MEDICINE >> TECHNOLOGY

Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association

conduct of Sunesis' clinical trials and manufacturing of SNS-595 and SNS- 032. These and other risk factors are discussed under "Risk Factors" and elsewhere in Sunesis' annual report on Form 10-K for the year ended December 31, 2006 and other filings with the Securities and Exchange Commission. Sunesis expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. http://www.sunesis.com.

CONTACT: investors, Eric Bjerkholt, SVP, Corporate Development & Financeof Sunesis Pharmaceuticals, Inc., +1-650-266-3717; or media, Karen L.Bergman, +1-650-575-1509, or Michelle Corral, +1-415-794-8662, both of BCCPartners for Sunesis Pharmaceuticals, Inc.

Web site: http://www.sunesis.com/

Ticker Symbol: (NASDAQ-NMS:SNSS)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company

Page: 1 2 3 4 5 6
Related medicine technology :

1. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
2. Sunesis Pharmaceuticals to Present Data at the 12th Congress of the European Hematology Association
3. Sunesis Presents Data Supporting SNS-032s Potential Anticancer Activity in Multiple Myeloma at the American Association for Cancer Research Meeting
4. Sunesis Pharmaceuticals to Present Data at the Annual Meeting of the American Association for Cancer Research
5. Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor Data Showing Broad Anti-Tumor Activity, Dosing Flexibility
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
10. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings

Post Your Comments:

(Date:10/10/2008)..., Oct. 10 /- Boston Scienti...schedule of the Company,s major,events and press a...tion,s,(CRF) twentieth annual Transcatheter Cardio...which runs from October 12 to 17 in Washington, D....ange of safety and,efficacy data on its TAXUS(R) E...

(Date:10/9/2008)...s for Increased Sales and Marketing Efforts to Acc...ip(R) System, MENLO PARK, Calif., Oct. 9 /PRNewsw...t of devices for the percutaneous repair of cardia...cutive team with the appointment of,Sean Cleary as...eting and,Chris Richardson, as vice president of s...

(Date:10/8/2008)...a., Oct. 8 /PRNewswire-USNewswire/ -- The facts ar... from HIV/AIDS in,sub-Saharan Africa. More than 35...frica have already died of AIDS. The Foundation fo...ure the dying and their families,find compassion a...,s,innovative partnering initiative links African ...

(Date:10/8/2008)...ab Program to be Discontinued and Headcount to be ...its Portfolio Review; Zanolimumab Program to be D... of Employees, COPE... A/S (OMX: GEN),announced today that it is discont...In addition, as a result of a portfolio review and...

[0] Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 [0] Evalve Expands Executive Leadership Team [0] In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices [0] Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio

...akthrough Will Aid in Developing Therapies to Prev...RYVILLE, Calif., May 10, 2007 /PRNewswire/ -- Kine...lopment company, announced,today the first method ...es in animals through the pathway known as reverse...n mechanism by which excess,cholesterol can be rem...

...POLIS, France, May 11, 2007 /PRNewswire-FirstCall/...pdate on the phase 2a,study for NCX 1000, which is... Pharma Inc. A preliminary analysis of 11 patient...tension confirmed,the safety profile of NCX 1000 b...pport the continuation of this clinical trial. As ...

Other Medicine Technology:KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 2 KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 3 NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 2 NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 3

KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan

(Date:10/13/2008)...eading Content Rights Management System, Supports... Content Spend, WEST CHESTER, Pa., Oct. 13 /PRNew...ding global pharmaceutical manufacturer has integr...primary platform for the,secure distribution, data...cs for their new product video content. Imperium i...

(Date:10/13/2008)...swire/ -- The National Coalition for,Quality Color...ncerns over,the National CT Colonography Study pub...Medicine. The evidence must be closely evaluated, ...y is not without significant,potential risks. The ...py,remains the "Gold Standard" for colorectal canc...

(Date:10/13/2008)...blem in daily life, survey shows, PORTLAND, Ore.,...three-quarters of people living with psoriasis say...e, according to a National Psoriasis,Foundation 20...viduals with psoriasis and psoriatic arthritis,als...ly lives, shapes their,feelings about themselves a...

(Date:10/13/2008)...swire/ -- During the Pri-Med New York,conference a...are providers,took a 20-question quiz prepared by ...n Somerset, NJ. The quiz tested basic knowledge of..., EMR software, and healthcare,administration., T... The average number,of correct answers was only 7....

Breaking Medicine News(10 mins):Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2 Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 2 Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 3 Health News:National Psoriasis Foundation Releases 2008 Study Results 2 Health News:MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource 2

[0] Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives![0] National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography [0] National Psoriasis Foundation Releases 2008 Study Results [0] MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource

...000 worth of unapproved dietary supplements in the...e Food and Drug Administration (FDA) agency had re...age Nutraceuticals L.L.C distributed the capsules....at the seized capsules, which are supposedly in vi...

...reast cancer cases in American women appears to ha.../ that a turning point may have reached in the nat...e latest federal data it was found that after a st...cer rate stopped rising in 2001 and may have start...

...ly poetic way to describe a disease that is the fu...s father’s life and, Galvin always knew, threatene...’s sitting out on the horizon that you know one da...ays Galvin, 37. “It’s something I’ve thought about...

...d of the conjoined twins from Wisconsin has been c...ork remains ahead of them.// The lead surgeon, Ro... optimistic about the preservation of neurological...ave decided not to separate the twins' shared tail...

Other Medicine News:Health News:Plateau Reached in the Battle against Breast Cancer 2 Health News:Plateau Reached in the Battle against Breast Cancer 3 Health News:Deadly Lung Disease Sends Patients on ‘Quest for Breath 2 Health News:Deadly Lung Disease Sends Patients on ‘Quest for Breath 3 Health News:Separation of Spinal Cord of Conjoined Twins Completed Successfully 2

Raids By US Marshals Uncovers Cache’ Of Unapproved Drug Plateau Reached in the Battle against Breast Cancer Deadly Lung Disease Sends Patients on ‘Quest for Breath Separation of Spinal Cord of Conjoined Twins Completed Successfully

Gentamicin Reagent Solution (10 mg/ml) liquid

LB Agar plates with 0.1mM EDTA.

Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride.

2.5% Soytone, 4.8% Yeast Extract, 0.025% Magnesium Sulfate, 130mM Calcium Chloride.

Medicine Products:

Gibco Gentamicin Reagent Solution (10 mg/ml) liquid LB Agar Plates EDTA-0.1 LB-BROTH, liquid, 10 g NaCl Inoculum Broth with Calcium Chloride

( conduct of Sunesis' clinical trials and...)Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association,Health